Vanda Pharmaceuticals Inc.
VNDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,900 | $2,509 | $6,275 | $33,152 |
| Dep. & Amort. | $8,132 | $3,010 | $2,733 | $2,841 |
| Deferred Tax | -$6,482 | -$1,286 | $1,130 | $6,745 |
| Stock-Based Comp. | $12,432 | $14,040 | $0 | $0 |
| Change in WC | -$6,558 | -$747 | $6,074 | $2,737 |
| Other Non-Cash | -$4,381 | -$4,725 | $15,772 | $18,739 |
| Operating Cash Flow | -$15,757 | $12,801 | $31,984 | $64,214 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$490 | -$383 | -$679 | -$552 |
| Net Acquisitions | -$4,229 | -$100,665 | $0 | $0 |
| Inv. Purchases | -$364,773 | -$512,606 | -$349,258 | -$420,461 |
| Inv. Sales/Matur. | $352,062 | $601,598 | $399,862 | $344,317 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$17,430 | -$12,056 | $49,925 | -$76,696 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$155 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $734 | $3,550 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$155 | $0 | $734 | $3,550 |
| Forex Effect | -$163 | $47 | $315 | -$85 |
| Net Chg. in Cash | -$33,505 | $792 | $82,958 | -$9,017 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $136,290 | $135,498 | $52,071 | $61,088 |
| End Cash | $102,785 | $136,290 | $135,029 | $52,071 |
| Free Cash Flow | -$16,247 | $12,418 | $31,305 | $63,662 |